<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04838171</url>
  </required_header>
  <id_info>
    <org_study_id>QEL-RP-001</org_study_id>
    <nct_id>NCT04838171</nct_id>
  </id_info>
  <brief_title>Prospective Study of White Blood Cells</brief_title>
  <official_title>Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Quell Therapeutics Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Quell Therapeutics Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate white blood cells from volunteering donors to&#xD;
      support the development of engineered regulatory T cell therapies.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 24, 2021</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>WBC characterisation to support the development of engineered regulatory T cells.</measure>
    <time_frame>5 years</time_frame>
    <description>number, type and function of white blood cells in healthy controls and in patients</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Autoimmune Diseases</condition>
  <condition>Inflammation</condition>
  <condition>Rejection; Transplant, Liver</condition>
  <arm_group>
    <arm_group_label>Specimen collection to support development of engineering Treg</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>White blood cell and blood collection</intervention_name>
    <description>Mononucleocytes will be collected via apheresis</description>
    <arm_group_label>Specimen collection to support development of engineering Treg</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteers willing to provide white blood cells for research.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        No additional inclusion/ exclusion criteria will be applied by Quell other than those&#xD;
        specified by the consenting institutions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David Collin</last_name>
    <phone>+4(0)2070969012</phone>
    <email>contact@quell-tx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Quell Investigator Site 01</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autoimmune Diseases</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

